Agala, Ponciana A.

HRN: 23-84-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/04/2023
10/12/2023
IV
600mg
QID
Cellulitis Right Leg
Waiting Final Action 
10/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/04/2023
10/12/2023
IV
600mg
QID
Cellulitis Right Leg
Waiting Final Action 
10/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/04/2023
10/10/2023
IV
1.5gm
Q6H
UTI
Waiting Final Action 
10/04/2023
FLUCONAZOLE 150MG (CAP)
10/04/2023
10/10/2023
PO
150mgtab
Od
Fungal Lesions On Cellulits Right Leg
Waiting Final Action 
10/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2023
10/20/2023
IVT
4.5g
Q6
Cellulitis; Hepatic Enceph
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: